Promising strategies to minimize secondary brain injury after head trauma

Hülya Bayir1, Robert S B Clark, Patrick M Kochanek

  • 1Safar Center for Resuscitation Research and Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Critical Care Medicine
|January 25, 2003
PubMed
Abstract

Insights

Novel treatments for severe traumatic brain injury (TBI) show promise. Four strategies, including dexanabinol, hypertonic saline, mild hypothermia, and decompressive craniectomy, target multiple mechanisms for TBI recovery.

Area of Science:

  • Neuroscience
  • Trauma Surgery
  • Pharmacology

Background:

  • Severe traumatic brain injury (TBI) presents significant management challenges.
  • Current treatment paradigms for severe TBI have limitations.
  • There is a critical need for innovative therapeutic strategies.

Purpose of the Study:

  • To review emerging therapeutic approaches for severe traumatic brain injury (TBI).
  • To identify promising treatments currently under investigation for TBI.

Main Methods:

  • A comprehensive review of 83 studies was conducted.
  • Studies included both experimental models and human clinical trials for TBI.
  • Focus was on novel therapeutic interventions for severe TBI.

Main Results:

  • Four therapeutic strategies demonstrated significant promise in clinical trials for severe TBI.
  • These include the pharmacologic agent dexanabinol, hypertonic saline, mild hypothermia, and decompressive craniectomy.
  • All promising therapies target multiple underlying mechanisms of TBI.

Conclusions:

  • Dexanabinol, hypertonic saline, mild hypothermia, and decompressive craniectomy are leading novel treatments for severe TBI.
  • The multi-target approach of these therapies is a key factor in their potential success.
  • Further clinical investigation is warranted for these promising TBI treatments.